BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37147453)

  • 1. Succinylation-associated lncRNA signature to predict the prognosis of colon cancer based on integrative bioinformatics analysis.
    Zhang SM; Shen C; Gu J; Li J; Jiang X; Wu Z; Shen A
    Sci Rep; 2023 May; 13(1):7366. PubMed ID: 37147453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
    Ma B; Li Y; Ren Y
    Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer.
    Liu Z; Mi M; Li X; Zheng X; Wu G; Zhang L
    J Cell Mol Med; 2020 Nov; 24(21):12444-12456. PubMed ID: 32967061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An m7G-related lncRNA signature predicts prognosis and reveals the immune microenvironment in bladder cancer.
    Li Z; Zhao J; Huang X; Wang J
    Sci Rep; 2023 Mar; 13(1):4302. PubMed ID: 36922569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and predictive value of a lncRNA signature in patients with stage II colon cancer.
    Qu A; Wang Q; Chang Q; Liu J; Yang Y; Zhang X; Zhang Y; Zhang X; Wang H; Zhang Y
    Sci Rep; 2023 Jan; 13(1):1350. PubMed ID: 36693876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a novel lysosome-related LncRNA signature for predicting prognosis and the immune landscape features in colon cancer.
    Li F; Wang W; Lai G; Lan S; Lv L; Wang S; Liu X; Zheng J
    Sci Rep; 2024 Jan; 14(1):622. PubMed ID: 38182713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of autophagy-related long non-coding RNA prognostic signature for breast cancer.
    Wu Q; Li Q; Zhu W; Zhang X; Li H
    J Cell Mol Med; 2021 Apr; 25(8):4088-4098. PubMed ID: 33694315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer.
    Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J
    J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The m7G-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumour Immune Infiltration in Colon Cancer.
    Liu L; Wu Y; Chen W; Li Y; Yu J; Zhang G; Fu P; Huang L; Xiong J; Jie Z
    Front Genet; 2022; 13():892589. PubMed ID: 35846130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer.
    Zeng J; Li M; Dai K; Zuo B; Guo J; Zang L
    Pathol Oncol Res; 2022; 28():1610643. PubMed ID: 36419649
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism-related lncRNAs signature to predict the prognosis of colon adenocarcinoma.
    Sun Y; Liu B; Xiao B; Jiang X; Xiang JJ; Xie J; Hu XM
    Cancer Med; 2023 Mar; 12(5):5994-6008. PubMed ID: 36366731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An innovative pyroptosis-related long-noncoding-RNA signature predicts the prognosis of gastric cancer
    Xiong S; Jin L; Zeng C; Ma H; Xie L; Liu S
    Pathol Oncol Res; 2022; 28():1610712. PubMed ID: 36567977
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of a novel five-lncRNA prognostic signature for predicting overall survival in elderly patients with breast cancer.
    Luo Y; Zhang Y; Wu YX; Li HB; Shen D; Che YQ
    J Clin Lab Anal; 2022 Jan; 36(1):e24172. PubMed ID: 34894405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
    Zhang Z; Wang J; Han W; Zhao L
    BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cox-LASSO Analysis Reveals a Ten-lncRNA Signature to Predict Outcomes in Patients with High-Grade Serous Ovarian Cancer.
    Xu L; Wu Y; Che X; Zhao J; Wang F; Wang P; Qu X; Liu Y; Li Z
    DNA Cell Biol; 2019 Dec; 38(12):1519-1528. PubMed ID: 31657627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Seven-lncRNA Immune Risk Signature and Construction of a Predictive Nomogram for Lung Adenocarcinoma.
    Jin D; Song Y; Chen Y; Zhang P
    Biomed Res Int; 2020; 2020():7929132. PubMed ID: 32596372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.